Trials / Completed
CompletedNCT01140633
Novel Measures and Theory of Pediatric Antiretroviral Therapy Adherence in Uganda
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 46 (actual)
- Sponsor
- Massachusetts General Hospital · Academic / Other
- Sex
- All
- Age
- 1 Year – 10 Years
- Healthy volunteers
- Not accepted
Summary
Current measures of adherence detect problems weeks to months after they occur. Because the HIV virus rapidly begins replicating and mutating in the absence of effective antiretroviral therapy, treatment failure may develop before an intervention can be deployed. Real-time objective adherence monitoring could redirect efforts from a reactive response to the proactive prevention of treatment failure. Because adherence is so closely associated with viral suppression, accurate adherence monitoring could also strategically limit viral monitoring only to those patients at a defined risk for viral rebound. This observational study is assessing a wireless adherence monitoring device and mobile phone-based adherence data collection among caregivers of children under the age of ten years in Mbarara, Uganda. It involves both quantitative and qualitative measures of the feasibility and acceptability of these measures, as well as circumstances of adherence lapses and other individual and cultural factors affecting adherence. The qualitative data will be used to explore models of adherence behavior, which will likely include the child-caregiver dynamic, the child's mental and physical health, and social support mechanism.
Detailed description
See above.
Conditions
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2011-01-01
- Completion
- 2012-08-01
- First posted
- 2010-06-09
- Last updated
- 2013-09-02
Locations
1 site across 1 country: Uganda
Source: ClinicalTrials.gov record NCT01140633. Inclusion in this directory is not an endorsement.